The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Organelle targeting: third level of drug targeting
Open accessAbstract
Drug discovery and drug delivery are two main aspects for treatment of a variety of disorders. However, the real bottleneck associated with systemic drug administration is the lack of target-specific affinity toward a pathological site, resulting in systemic toxicity and innumerable other side effects as well as higher dosage requirement for efficacy. An attractive strategy to increase the therapeutic index of a drug is to specifically deliver the therapeutic molecule in its active form, not only into target tissue, nor even to target cells, but more importantly, into the targeted organelle, ie, to its intracellular therapeutic active site. This would ensure improved efficacy and minimize toxicity. Cancer chemotherapy today faces the major challenge of delivering chemotherapeutic drugs exclusively to tumor cells, while sparing normal proliferating cells. Nanoparticles play a crucial role by acting as a vehicle for delivery of drugs to target sites inside tumor cells. In this review, we spotlight active and passive targeting, followed by discussion of the importance of targeting to specific cell organelles and the potential role of cell-penetrating peptides. Finally, the discussion will address the strategies for drug/DNA targeting to lysosomes, mitochondria, nuclei and Golgi/endoplasmic reticulum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue
de Duve, C., Pressman, B. C., Gianetto, R., Wattiaux, R., & Appelmans, F. (1955) · Biochemical Journal · doi:10.1042/bj0600604 · Cited by 4,174
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
Molecular mechanism and physiological functions of clathrin-mediated endocytosis
McMahon, H. T., & Boucrot, E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3151 · Cited by 2,223
Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662
The Sequence of the Human Genome
Venter, J. C., Smith, H. O., & Adams, M. D. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.237016 · Cited by 1,648
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
Robbins, J., Dilwortht, S. M., Laskey, R. A., & Dingwall, C. (1991) · Cell · doi:10.1016/0092-8674(91)90245-t · Cited by 1,489
Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery
Khalil, I. A., Kogure, K., Akita, H., & Harashima, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.8 · Cited by 1,240
Cancer's Molecular Sweet Tooth and the Warburg Effect
Kim, J.-W., & Dang, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1501 · Cited by 1,215
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Transport into and out of the Nucleus
Macara, I. G. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.4.570-594.2001 · Cited by 905
Nabel, G. J., Nabel, E. G., Yang, Z. Y., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., & Chang, A. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11307 · Cited by 882
Neu, M., Fischer, D., & Kissel, T. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.773 · Cited by 866
Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting
Greish, K. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_3 · Cited by 841
The mTOR Signalling Pathway in Human Cancer
Pópulo, H., Lopes, J. M., & Soares, P. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021886 · Cited by 830
Lindgren, M., Hällbrink, M., Prochiantz, A., & Langel, Ü. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01447-4 · Cited by 803
A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides
Duchardt, F., Fotin‐Mleczek, M., Schwarz, H., Fischer, R., & Brock, R. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00572.x · Cited by 771
Caveolae/raft-dependent endocytosis
Nabi, I. R., & Le, P. U. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302028 · Cited by 749
Pelkmans, L., & Helenius, A. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30501.x · Cited by 747
Pollard, H., Remy, J.-S., Loussouarn, G., Demolombe, S., Behr, J.-P., & Escande, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7507 · Cited by 711
Subcellular targeting strategies for drug design and delivery
Rajendran, L., Knölker, H.-J., & Simons, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2897 · Cited by 708
Application of Nanotechnology in Cancer Therapy and Imaging
Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 700
Kang, B., Mackey, M. A., & El-Sayed, M. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9102698 · Cited by 674
Cationic TAT peptide transduction domain enters cells by macropinocytosis
Kaplan, I. M., Wadia, J. S., & Dowdy, S. F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.018 · Cited by 668
Antennapedia homeobox peptide regulates neural morphogenesis.
Joliot, A., Pernelle, C., Deagostini-Bazin, H., & Prochiantz, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1864 · Cited by 654
Breaking down the barriers: siRNA delivery and endosome escape
Dominska, M., & Dykxhoorn, D. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.066399 · Cited by 630
Nonviral gene therapy: promises and challenges
Li, S., & Huang, L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301110 · Cited by 614
Structural Basis of Presequence Recognition by the Mitochondrial Protein Import Receptor Tom20
Abe, Y., Shodai, T., Muto, T., Mihara, K., Torii, H., Nishikawa, S.-I., Endo, T., & Kohda, D. (2000) · Cell · doi:10.1016/s0092-8674(00)80691-1 · Cited by 582
The determination and interpretation of the therapeutic index in drug development
Muller, P. Y., & Milton, M. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3801 · Cited by 563
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Mitochondrion as a Novel Target of Anticancer Chemotherapy
Costantini, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1042 · Cited by 532
Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins
Fittipaldi, A., Ferrari, A., Zoppé, M., Arcangeli, C., Pellegrini, V., Beltram, F., & Giacca, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303045200 · Cited by 475
Meier, O., Boucke, K., Hammer, S. V., Keller, S., Stidwill, R. P., Hemmi, S., & Greber, U. F. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200112067 · Cited by 468
Selective targeting of an antioxidant to mitochondria
Smith, R. A. J., Porteous, C. M., Coulter, C. V., & Murphy, M. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00543.x · Cited by 466
Clathrin- and caveolin-1–independent endocytosis
Damm, E.-M., Pelkmans, L., Kartenbeck, J., Mezzacasa, A., Kurzchalia, T., & Helenius, A. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407113 · Cited by 454
Cell-penetrating and cell-targeting peptides in drug delivery
Vivès, E., Schmidt, J., & Pèlegrin, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.03.001 · Cited by 441
Transferrin/transferrin receptor‐mediated drug delivery
Li, H., & Qian, Z. M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10008 · Cited by 441
Drug delivery to mitochondria: the key to mitochondrial medicine
Murphy, M. P., & Smith, R. A. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00069-1 · Cited by 426
Roles of Mitochondria in Health and Disease
Duchen, M. R. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s96 · Cited by 425
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., & D'Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419
Nanosystems in Drug Targeting: Opportunities and Challenges
Vasir, J. K., Reddy, M. K., & Labhasetwar, V. D. (2005) · Current Nanoscience · doi:10.2174/1573413052953110 · Cited by 414
Tünnemann, G., Martin, R. M., Haupt, S., Patsch, C., Edenhofer, F., & Cardoso, M. C. (2006) · The FASEB Journal · doi:10.1096/fj.05-5523com · Cited by 402
Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells
Muratovska, A., & Eccles, M. R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01505-9 · Cited by 390
Wang, Q., Mora-Jensen, H., Weniger, M. A., Perez-Galan, P., Wolford, C., Hai, T., Ron, D., Chen, W., Trenkle, W., Wiestner, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807611106 · Cited by 343
Tat Peptide as an Efficient Molecule To Translocate Gold Nanoparticles into the Cell Nucleus
de la Fuente, J. M., & Berry, C. C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050033+ · Cited by 342
Cell-penetrating peptides: A comparative membrane toxicity study
Saar, K., Lindgren, M., Hansen, M., Eiríksdóttir, E., Jiang, Y., Rosenthal-Aizman, K., Sassian, M., & Langel, Ü. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.07.033 · Cited by 290
(2004) · The Women's Oncology Review · doi:10.3109/14733400410001727592 · Cited by 288
Traffic Jam: A Compendium of Human Diseases that Affect Intracellular Transport Processes
Aridor, M., & Hannan, L. A. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.011104.x · Cited by 278
Kruth, H. S., Jones, N. L., Huang, W., Zhao, B., Ishii, I., Chang, J., Combs, C. A., Malide, D., & Zhang, W.-Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407167200 · Cited by 275
Lai, S. K., Hida, K., Man, S. T., Chen, C., Machamer, C., Schroer, T. A., & Hanes, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.021 · Cited by 264
Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study
El-Andaloussi, S., Järver, P., Johansson, H. J., & Langel, Ü. (2007) · Biochemical Journal · doi:10.1042/bj20070507 · Cited by 259
Lübke, T., Lobel, P., & Sleat, D. E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.018 · Cited by 259
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome
Suzuki, R., Takizawa, T., Kuwata, Y., Mutoh, M., Ishiguro, N., Utoguchi, N., Shinohara, A., Eriguchi, M., Yanagie, H., & Maruyama, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.010 · Cited by 250
Signal transduction during Fc receptor-mediated phagocytosis
García-García, E., & Rosales, C. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.6.1092 · Cited by 249
Ligand-Targeted Liposomes for Cancer Treatment
Sapra, P., Tyagi, P., & Allen, T. (2005) · Current Drug Delivery · doi:10.2174/156720105774370159 · Cited by 246
Endocytosis: clathrin-mediated membrane budding
Ungewickell, E. J., & Hinrichsen, L. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.05.003 · Cited by 241
Weiss, M. J., Wong, J. R., Ha, C. S., Bleday, R., Salem, R. R., Steele, G. D., & Chen, L. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5444 · Cited by 240
Paschen, W., & Frandsen, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00623.x · Cited by 239
Glinsky, V. V., Glinsky, G. V., Rittenhouse‐Olson, K., Huflejt, M. E., Glinskii, O. V., Deutscher, S. L., & Quinn, T. P. (2001) · PubMed · Cited by 239
Gene therapy for mitochondrial disease by delivering restriction endonucleaseSmaI into mitochondria
Tanaka, M., Borgeld, H.-J., Zhang, J., Muramatsu, S.-I., Gong, J.-S., Yoneda, M., Maruyama, W., Naoi, M., Ibi, T., Sahashi, K., et al. (2002) · Journal of Biomedical Science · doi:10.1007/bf02254980 · Cited by 232
Evolving questions and paradigm shifts in endoplasmic‐reticulum‐associated degradation (ERAD)
McCracken, A. A., & Brodsky, J. L. (2003) · BioEssays · doi:10.1002/bies.10320 · Cited by 221
Lysosomal Storage Disease: Revealing Lysosomal Function and Physiology
Parkinson-Lawrence, E. J., Shandala, T., Prodoehl, M., Plew, R., Borlace, G. N., & Brooks, D. A. (2010) · Physiology · doi:10.1152/physiol.00041.2009 · Cited by 220
Diverse functions with a common regulator: Ubiquitin takes command of an AAA ATPase
Ye, Y. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.01.005 · Cited by 213
Kidd, J. F., Pilkington, M. F., Schell, M. J., Fogarty, K. E., Skepper, J. N., Taylor, C. W., & Thorn, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106802200 · Cited by 205
Ulbrich, W., & Lamprecht, A. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0285.focus · Cited by 197
DQAsomes: A Novel Potential Drug and Gene Delivery System Made from Dequalinium™
Weissig, V., Lasch, J., Erdos, G., Meyer, H. W., Rowe, T. C., & Hughes, J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011991307631 · Cited by 193
Nuclear Targeting of Mutant Huntingtin Increases Toxicity
Peters, M. F., Nucifora, F. C., Kushi, J., Seaman, H. C., Cooper, J. K., Herring, W. J., Dawson, V. L., Dawson, T. M., & Ross, C. A. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0773 · Cited by 191
Cramer, W. (1938) · BMJ · doi:10.1136/bmj.1.4032.829 · Cited by 179
André, N., Braguer, D., Brasseur, G., Gonçalvès, A., Lemesle-Meunier, D., Guise, S., Jordan, M. A., & Briand, C. M. (2000) · PubMed · Cited by 178
Bagshaw, R. D., Mahuran, D. J., & Callahan, J. W. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400128-mcp200 · Cited by 175
Drenan, R. M., Liu, X., Bertram, P. G., & Zheng, X.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305912200 · Cited by 160
Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes
Oliveira, S., VANROOY, I., Kranenburg, O., Storm, G., & Schiffelers, R. M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.050 · Cited by 155
Distinct Pathways for Stimulation of Cytochrome cRelease by Etoposide
Robertson, J. D., Gogvadze, V. G., Zhivotovsky, B., & Orrenius, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000518200 · Cited by 153
Flierl, A., Jackson, C., Cottrell, B. A., Murdock, D. G., Seibel, P., & Wallace, D. C. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00037-6 · Cited by 151
Wang, Y., Liu, X., Sun, T., Xiong, M., & Wang, J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.021 · Cited by 151
ER–Golgi network—A future target for anti-cancer therapy
Włodkowic, D., Skommer, J., McGuinness, D., Hillier, C., & Darżynkiewicz, Z. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.05.025 · Cited by 136
Medeiros-Neto, G. A., Kim, P. S., Yoo, S. E., VONO, J., Targovnik, H. M., Camargo, R., Hossain, S. A., & Arvan, P. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119112 · Cited by 131
Endoplasmic reticulum storage diseases
Spiess, M. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.09861 · Cited by 130
(2004) · The Women s Oncology Review · doi:10.1080/14733400410001727592 · Cited by 120
Comparison of Cationic and Amphipathic Cell Penetrating Peptides for siRNA Delivery and Efficacy
Mo, R. H., Zaro, J. L., & Shen, W. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200481g · Cited by 116
Nuclear Targeting of Adenovirus Type 2 Requires CRM1-mediated Nuclear Export
Strunze, S., Trotman, L. C., Boucke, K., & Greber, U. F. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-02-0121 · Cited by 114
Endoplasmic Reticulum and Golgi Localization Sequences for Mammalian Target of Rapamycin
Liu, X., & Zheng, X.-F. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0406 · Cited by 114
Review. The endoplasmic reticulum: a target for new anticancer drugs.
Boelens, J., Lust, S., Offner, F. C., Bracke, M., & Vanhoecke, B. W. A. (2007) · PubMed · Cited by 113
DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria
Weissig, V., D’Souza, G. G. M., & Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00392-3 · Cited by 112
D’Souza, G. G. M., Boddapati, S. V., & Weissig, V. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.07.001 · Cited by 111
Challenges facing colloidal delivery systems: From synthesis to the clinic
Johnston, A. P. R., Such, G. K., Ng, S. L., & Caruso, F. (2010) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.11.003 · Cited by 108
Weissig, V., Cheng, S.-M., & D’Souza, G. G. M. (2004) · Mitochondrion · doi:10.1016/j.mito.2003.11.002 · Cited by 100
Using nuclear targeting signals to enhance non‐viral gene transfer
Chan, C., & Jans, D. A. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01061.x · Cited by 89
New Strategies for Enzyme Replacement Therapy for Lysosomal Storage Diseases
Grubb, J. H., Vogler, C. A., & Sly, W. S. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0920 · Cited by 81
D’Souza, G. G. M., Cheng, S.-M., Boddapati, S. V., Horobin, R. W., & Weissig, V. (2008) · Journal of drug targeting · doi:10.1080/10611860802228855 · Cited by 80
Import of Nuclear‐Encoded Proteins into Mitochondria
Stojanovski, D., Johnston, A. J., Streimann, I., Hoogenraad, N. J., & Ryan, M. T. (2003) · Experimental Physiology · doi:10.1113/eph8802501 · Cited by 72
The sorting and trafficking of lysosomal proteins.
Ni, X., Canuel, M., & Morales, C. R. (2006) · PubMed · doi:10.14670/hh-21.899 · Cited by 65
Effect of Cell-Based Intercellular Delivery of Transcription Factor GATA4 on Ischemic Cardiomyopathy
Bian, J. T., Popović, Z., Benejam, C., Kiedrowski, M. J., Rodriguez, L. L., & Penn, M. S. (2007) · Circulation Research · doi:10.1161/01.res.0000269778.75877.68 · Cited by 64
Endosomal Endothelin-converting Enzyme-1
Cottrell, G. S., Padilla, B. E., Amadesi, S., Poole, D. P., Murphy, J. E., Hardt, M., Roosterman, D., Steinhoff, M. S., & Bunnett, N. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.026674 · Cited by 63
The centenarian Golgi apparatus
Mazzarello, P., & Bentivoglio, M. (1998) · Nature · doi:10.1038/33266 · Cited by 60
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
Kersemans, V., & Cornelissen, B. T. (2010) · Pharmaceuticals · doi:10.3390/ph3030600 · Cited by 51
Sly, W. S., & Vogler, C. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102175599 · Cited by 48
Future prospects of nanoparticles on brain targeted drug delivery
Chakraborty, C., Sarkar, B., Hsu, C. H., Wen, Z., Lin, C. S., & Shieh, P.-C. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9759-2 · Cited by 46
Intracellular Delivery of Oligonucleotide Conjugates and Dendrimer Complexes
Juliano, R. L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.011 · Cited by 46
Maniti, O., Blanchard, E., Trugnan, G., Lamazière, A., & Ayala‐Sanmartín, J. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.02.010 · Cited by 45
Peptide-Mediated Liposomal Drug Delivery System Targeting Tumor Blood Vessels in Anticancer Therapy
Wu, H., & Chang, D.-K. (2010) · Journal of Oncology · doi:10.1155/2010/723798 · Cited by 40
Targeted Delivery of Oligodeoxynucleotides to Mouse Lung Endothelial Cells in Vitro and in Vivo
Wilson, A. S., Zhou, W. Y., Champion, H. C., Alber, S. M., Tang, Z.-L., Kennel, S. J., Watkins, S. C., Huang, L., Pitt, B. R., & Li, S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.005 · Cited by 38
An antigenomic strategy for treating heteroplasmic mtDNA disorders
Taylor, R. W., Wardell, T. M., Smith, P., Muratovska, A., Murphy, M. P., Turnbull, D. M., & Lightowlers, R. N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00130-2 · Cited by 31
Review article: Targeted drug delivery in treatment of intestinal diseases
WIKBERG, M., Ulmius, J., & Ragnarsson, G. B. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1997.tb00815.x · Cited by 30
Behnke, J., Eskelinen, E., Säftig, P., & Schröder, B. (2011) · Biochemical Journal · doi:10.1042/bj20101396 · Cited by 28
Importin α/β-mediated nuclear protein import is regulated in a cell cycle-dependent manner
Yasuhara, N., Takeda, E., Inoue, H., Kotera, I., & Yoneda, Y. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.010 · Cited by 28
Ballestrero, A., Garuti, A., Cirmena, G., Rocco, I., Palermo, C., Nencioni, A., Scabini, S., Zoppoli, G. M., Parodi, S., & Patrone, F. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912800190956 · Cited by 25
Activation of signal pathways and the resistance to anti‐EGFR treatment in colorectal cancer
Chen, J., Huang, X., & Katsifis, A. G. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22905 · Cited by 19
Approaches to Achieving Sub-cellular Targeting of Bioactives Using Pharmaceutical Nanocarriers
Solomon, M. A., & D’Souza, G. G. M. (2011) · Fundamental biomedical technologies · doi:10.1007/978-94-007-1248-5_2 · Cited by 8
DQAsomes as Mitochondria-Targeted Nanocarriers for Anti-Cancer Drugs
Cheng, S.-M., Boddapati, S. V., D’Souza, G. G. M., & Weissig, V. (2006) · CRC Press eBooks · doi:10.1201/9781420006636-38 · Cited by 8
An Introduction to Subcellular Nanomedicine: Current Trends and Future Developments
D’Souza, G. G. M., & Weissig, V. (2010) · Wiley eBooks · doi:10.1002/9780470875780.ch1 · Cited by 4
DQAsomes as Mitochondria-Targeted Nanocarriers for Anti-Cancer Drugs
D’Souza, G. G. M., Boddapati, S. V., Cheng, S.-M., & Weissig, V. (2006) · CRC Press eBooks · doi:10.1201/9781420006636.ch38 · Cited by 2
Cited by
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Discerning the Chemistry in Individual Organelles with Small‐Molecule Fluorescent Probes
Xu, W., Zeng, Z., Jiang, J., Chang, Y., & Yuan, L. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510721 · Cited by 808
Poynton, F. E., Bright, S. A., Blasco, S., Williams, D. C., Kelly, J. M., & Gunnlaugsson, T. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00680b · Cited by 421
Hu, Q., Gao, M., Feng, G., & Liu, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408897 · Cited by 419
Unveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
Metadata
- Authors
- Padh, H., & Sakhrani, N.
- Venue
- Drug Design, Development and Therapy
- Publisher
- Informa UK Limited
- Published
- 2013-07
- Volume
- 7
- Pages
- 585
- ISSN
- 1177-8881 (ISSN-L)
- OpenAlex
- W2089591522
- Cited by
- 269
- References
- 124
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.